These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7321605)

  • 1. Permeability to oxygen (PmO2) of cuprophan haemodialysis membranes.
    Borovetz HS; Mateer DD; Hardesty RL
    Med Biol Eng Comput; 1981 Jul; 19(4):391-7. PubMed ID: 7321605
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of hemodialysis with frequent use of cuprophan and polysulfone membranes on activation of complement in patients with chronic renal failure].
    Zukowska-Szczechowska E; Moczulski D; Grzeszczak W; Gosek K; Augustyn M; Staszewicz P
    Pol Arch Med Wewn; 1996 Nov; 96(5):458-68. PubMed ID: 9091856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biocompatibility of a new high-permeability modified cellulose membrane for haemodialysis.
    Ward RA; Schaefer RM; Falkenhagen D; Joshua MS; Heidland A; Klinkmann H; Gurland HJ
    Nephrol Dial Transplant; 1993; 8(1):47-53. PubMed ID: 8381935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of dialysis procedure, membrane surface and membrane material on iopromide elimination in patients with reduced kidney function.
    Matzkies FK; Reinecke H; Tombach B; Kosch M; Hegger K; Milius M; Hohage H; Kisters K; Kerber S; Schaefer RM
    Am J Nephrol; 2000; 20(4):300-4. PubMed ID: 10970983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodialysis-membrane biocompatibility and mortality of patients with dialysis-dependent acute renal failure: a prospective randomised multicentre trial. International Multicentre Study Group.
    Jörres A; Gahl GM; Dobis C; Polenakovic MH; Cakalaroski K; Rutkowski B; Kisielnicka E; Krieter DH; Rumpf KW; Guenther C; Gaus W; Hoegel J
    Lancet; 1999 Oct; 354(9187):1337-41. PubMed ID: 10533862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evaluation of heparinized Cuprophan hemodialysis membranes.
    Hinrichs WL; ten Hoopen HW; Engbers GH; Feijen J
    J Biomed Mater Res; 1997 Jun; 35(4):443-50. PubMed ID: 9189822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of cuprophan and polysulfone membranes on dialyzer reusability and intradialytic complications.
    Kadiri S; Kehinde Z; Arije A; Salako BL
    Afr J Med Med Sci; 2001 Sep; 30(3):191-4. PubMed ID: 14510127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Permeability of dialysis membranes for endotoxins. Clinical and experimental results].
    Passavanti G; Buongiorno E; De Fino G; Fumarola D; Coratelli P
    Cas Lek Cesk; 1990 Mar; 129(10):289-91. PubMed ID: 2340547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta 2-microglobulin kinetics during haemodialysis and haemofiltration.
    Flöge J; Granolleras C; Bingel M; Deschodt G; Branger B; Oules R; Koch KM; Shaldon S
    Nephrol Dial Transplant; 1987; 1(4):223-8. PubMed ID: 3110678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetically modified cellulose: an alternative to synthetic membranes for use in haemodialysis?
    Hoenich NA; Woffindin C; Stamp S; Roberts SJ; Turnbull J
    Biomaterials; 1997 Oct; 18(19):1299-303. PubMed ID: 9307219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Permeability for middle and higher molecular weight substances. Comparison between polysulfone and cuprophan dialyzers.
    Brunner H; Mann H; Stiller S; Sieberth HG
    Contrib Nephrol; 1985; 46():33-42. PubMed ID: 4006479
    [No Abstract]   [Full Text] [Related]  

  • 12. [Does multiple use of a cuprophan dialyser influence levels of chromium and cadmium during hemodialysis in patients with chronic kidney failure?].
    Małecka J; Grzeszczak W; Zukowska-Szczechowska E; Jendryczko A; Baczyński R
    Pol Arch Med Wewn; 1995 Dec; 94(6):482-7. PubMed ID: 8618810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxygen permeability of carbon-surfaced microporous membranes.
    Borovetz HS; Mateer DD; Hardesty RL; Haubold AD
    J Biomed Mater Res; 1980 Mar; 14(2):145-54. PubMed ID: 7358742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interaction between blood and dialysis membrane].
    Szepietowski T; Orłowski A
    Polim Med; 1991; 21(3-4):3-13. PubMed ID: 1822594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe reactions to Cuprophan capillary dialyzers.
    Popli S; Ing TS; Daugirdas JT; Kheirbek AO; Viol GW; Vilbar RM; Gandhi VC
    Artif Organs; 1982 Aug; 6(3):312-5. PubMed ID: 7181733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodialysis membranes modulate chronically the production of TNF alpha, IL1 beta and IL6.
    Mege JL; Olmer M; Purgus R; Bertocchio P; Farnarier C; Kaplanski S; Capo C; Bongrand P
    Nephrol Dial Transplant; 1991; 6(11):868-75. PubMed ID: 1775252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta 2-Microglobulin and other low molecular weight proteins in haemodiafiltrates and in haemofiltrates.
    Montali U; Pilone N; Cioni L; Ronca G
    Int J Tissue React; 1984; 6(1):71-4. PubMed ID: 6370888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leucopenia, hypoxia and complement activation in haemodialysis. Three unrelated phenomena.
    de Vinuesa SG; Resano M; Luño J; Gonzalez C; Barril G; Junco E; Valderrabano F
    Proc Eur Dial Transplant Assoc; 1983; 19():159-67. PubMed ID: 6878230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limulus amebocyte lysate reactivity, complement activation, and patients' symptoms. Comparison of dialyzer membranes.
    Moss AH; Hamrick RM; Shen SH
    ASAIO Trans; 1989; 35(4):812-5. PubMed ID: 2611049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficiency of three different hemodialysis membranes for plasma porphyrin removal.
    Fontanellas A; Herrero JA; Moran MJ; Coronel F; Sepulveda P; Barrientos A; Enriquez De Salamanca R
    Am J Kidney Dis; 1995 Jan; 25(1):30-3. PubMed ID: 7810529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.